Fairmount Funds Management LLC - 13 Jun 2025 SCHEDULE 13D Report for Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value

Filing Manager
Fairmount Funds Management LLC
Reporting Manager
Fairmount Funds Management LLC
Security
Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value
Shares outstanding
15,628,914 shares
Disclosed Ownership
3,124,220 shares
Ownership
20%
Form type
SCHEDULE 13D
Filing time
23 Jun 2025, 18:32:36 UTC
Date of event
13 Jun 2025
Next filing
08 Dec 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Fairmount Funds Management LLC 20% 3,124,220 0 3,124,220 /s/ Peter Harwin Peter Harwin, Managing Member 0001802528
Fairmount Healthcare Fund II L.P. 20% 3,124,220 0 3,124,220 /s/ Peter Harwin Peter Harwin, Managing Member 0001769651
Peter Evan Harwin 20% 3,124,220 0 3,124,220 /s/ Peter Harwin Peter Harwin 0001663607
Tomas Kiselak 20% 3,124,220 0 3,124,220 /s/ Tomas Kiselak Tomas Kiselak 0001830177